23 May 2013
Keywords: Lundbeck, Investment, Ossianix, CNS products, Onfi, Epilepsy, USA launch
Article | 03 January 2012
Privately-held US company Ossianix announced a strategic investment by Danish CNS drug specialist Lundbeck A/S (LUND: DC) in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 January 2012
4 January 2012
22 May 2013
© 2013 thepharmaletter.com